MPMark A. Peterzan

Mark A. Peterzan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark A. Peterzan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validation of the Hemodynamic Classification System for Hemodynamic‐Related Events in Patients With Durable Left Ventricular Assist Devices

    by Guglielmo Gallone, Luca Baldetti, Mailen Konicoff, Javier Ibero, Alba Maestro‐Benedicto, Andrew Morley‐Smith, Maria Monteagudo Vela, Francesca Fiorelli, Mark Peterzan, Gemma Edwards, et al.

    Background: Durable left ventricular assist device (dLVAD) physiology predisposes to right heart failure (RHF) and aortic insufficiency (AI), recently labeled hemodynamic‐related events (HDREs). We sought to validate the recently proposed dLVAD Hemodynamic Classification System for HDREs. Methods: RHF and AI HDREs were adjudicated, staged, and phenotyped on the basis of the Hemodynamic Classification System assessed at 6 months after dLVAD implantation. The primary outcome was a composite of HF hospitalization or cardiovascular death between 6 and 24 months after dLVAD implantation. Results: Among 183 qualifying consecutive patients with 6‐month assessments, RHF HDRE was adjudicated in all cases and AI HDRE in 161 (88.0%). Overall, 53 (29.0%) patients developed an RHF HDRE and 26 (16.0%) an AI HDRE (phenotypes: 39 isolated RHF, 15 isolated AI, 11 combined RHF–AI, 3 not adjudicated). At pre‐dLVAD assessment, age and pulmonary artery pulsatility index were independently associated with RHF HDRE and pre‐dLVAD AI and systolic pulmonary artery pressure with AI HDRE. RHF HDRE (adjusted hazard ratio [HR], 2.69 [95% CI, 1.14–6.34]; P =0.024), AI HDRE (adjusted HR, 4.21 [95% CI, 1.70–10.40]; P =0.002), and HDRE phenotypes (isolated RHF/AI HDRE versus no HDRE: adjusted HR, 2.80 [95% CI, 1.03–7.62]; P =0.044; combined RHF/AI HDRE versus no HDRE: adjusted HR, 4.53 [95% CI, 1.33–15.35]; P =0.015) were associated with the primary outcome. A graded increase in primary outcome was observed with increasing RHF and AI stages. Conclusions: We validated the dLVAD Hemodynamic Classification System for HDREs as a valuable tool to identify pathophysiological and clinical clusters of patients, linking it with significant prognostic implications. Its adoption may pave the way for targeted strategies aimed at mitigating HDREs and enhancing the long‐term success of dLVAD support.


  • Faculty Opinions recommendation of Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach.

    by Madalina Garbi, Mark Peterzan

    Mitral valve repair is recommended for primary mitral regurgitation (MR) when the regurgitation is severe and in the presence of symptoms or imaging evidence of left ventricular (LV) dilation or dysfunction. MR is characterized as severe when the echocardiography-determined regurgitant volume (RVol) is >60ml, based on a study relating RVol to all-cause mortality {1}. A cardiac magnetic resonance imaging (MRI)-determined RVol >55ml was found to discriminate cases more likely to develop a surgical indication {2}; however, the study we recommend is the first to relate MRI parameters with all-cause mortality. In 258 patients with asymptomatic moderate or severe primary MR, sinus rhythm and LV ejection fraction (LVEF) >0.60, the characterization of MR as moderate or severe had less inter-observer variability when performed with MRI rather than echocardiography (10 vs. 40%); furthermore, the MRI-determined RVol, LV end-systolic volume index and MR severity independently predicted all-cause mortality.


  • Faculty Opinions recommendation of Transcathether valve replacement and valve repair: review of procedures and intraprocedural echocardiographic imaging.

    by Madalina Garbi, Mark Peterzan

    This review covers the key factors and evidence the periprocedural imager for structural heart valve interventions should know and anticipate. Key intraprocedural checks during transcatheter aortic valve replacement and transcatheter mitral valve repair and a suggested 5-class grading of paraprosthetic valve regurgitation are given. Imaging and structural interventional approaches for the failing aortic (native valve, valve-in-valve), mitral (MitraClip, native valve replacement), prosthetic, and tricuspid valve are discussed. The review predates the COAPT and MITRA-FR trials, which assessed the use of MitraClip in secondary mitral regurgitation {1,2}.

  • Metabolic remodeling in hypertrophied and failing myocardium: a review

    by Mark A. Peterzan, Craig A. Lygate, Stefan Neubauer, Oliver J. Rider

    The energy starvation hypothesis proposes that maladaptive metabolic remodeling antedates, initiates, and maintains adverse contractile dysfunction in heart failure (HF). Better understanding of the cardiac metabolic phenotype and metabolic signaling could help identify the role metabolic remodeling plays within HF and the conditions known to transition toward HF, including “pathological” hypertrophy. In this review, we discuss metabolic phenotype and metabolic signaling in the contexts of pathological hypertrophy and HF. We discuss the significance of alterations in energy supply (substrate utilization, oxidative capacity, and phosphotransfer) and energy sensing using observations from human and animal disease models and models of manipulated energy supply/sensing. We aim to provide ways of thinking about metabolic remodeling that center around metabolic flexibility, capacity (reserve), and efficiency rather than around particular substrate preferences or transcriptomic profiles. We show that maladaptive metabolic remodeling takes multiple forms across multiple energy-handling domains. We suggest that lack of metabolic flexibility and reserve (substrate, oxidative, and phosphotransfer) represents a final common denominator ultimately compromising efficiency and contractile reserve in stressful contexts.